RU97103533A - DERIVATIVES OF N-SUBSTITUTED AZABICYCLOPTANE AS A NEUROLEPTIC MEANS - Google Patents

DERIVATIVES OF N-SUBSTITUTED AZABICYCLOPTANE AS A NEUROLEPTIC MEANS

Info

Publication number
RU97103533A
RU97103533A RU97103533/04A RU97103533A RU97103533A RU 97103533 A RU97103533 A RU 97103533A RU 97103533/04 A RU97103533/04 A RU 97103533/04A RU 97103533 A RU97103533 A RU 97103533A RU 97103533 A RU97103533 A RU 97103533A
Authority
RU
Russia
Prior art keywords
formula
group
substituted
chlorine
compound
Prior art date
Application number
RU97103533/04A
Other languages
Russian (ru)
Other versions
RU2160254C2 (en
Inventor
Штайнер Герд
Муншауер Райнер
Хегер Томас
Унгер Лилиане
Тешендорф Ханс-Юрген
Original Assignee
Басф Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4427647A external-priority patent/DE4427647A1/en
Application filed by Басф Акциенгезельшафт filed Critical Басф Акциенгезельшафт
Publication of RU97103533A publication Critical patent/RU97103533A/en
Application granted granted Critical
Publication of RU2160254C2 publication Critical patent/RU2160254C2/en

Links

Claims (4)

1. Производные N-замещенных 3-азабицикло[3.2.0]гептанов формулы I
Figure 00000001

где R1 означает нафтильную или фенантрильную группу, которые могут быть моно- или дизамещены атомами галоида,
n означает числа 0, 1, 2, 3 или 4,
A означает остаток формул
Figure 00000002

Figure 00000003

Figure 00000004

Figure 00000005

Figure 00000006

Figure 00000007

или нафтильную группу, которая может быть замещена галоидом,
R2 означает водород, гидроксильный остаток, алкильную группу, содержащую 1-4 атома углерода, нитрогруппу или метоксигруппу или фтор, хлор, бром или иод,
R3 означает водород, фтор или хлор,
R4 означает водород или метильную группу,
R5 означает водород или хлор,
и их соли с физиологически приемлемыми кислотами.
1. Derivatives of N-substituted 3-azabicyclo [3.2.0] heptanes of formula I
Figure 00000001

where R 1 means naphthyl or phenanthryl group, which can be mono - or disubstituted by halogen atoms,
n means the numbers 0, 1, 2, 3 or 4,
A means the remainder of the formulas
Figure 00000002

Figure 00000003

Figure 00000004

Figure 00000005

Figure 00000006

Figure 00000007

or naphthyl group which may be substituted by halogen,
R 2 means hydrogen, hydroxyl residue, alkyl group containing 1-4 carbon atoms, nitro group or methoxy group or fluorine, chlorine, bromine or iodine,
R 3 means hydrogen, fluorine or chlorine,
R 4 means hydrogen or methyl group,
R 5 means hydrogen or chlorine,
and their salts with physiologically acceptable acids.
2. Соединения формулы I по п. 1 для лечения заболеваний. 2. The compounds of formula I under item 1 for the treatment of diseases. 3. Способ лечения психозов, отличающийся тем, что больным дают эффективную дозу соединения формулы I по п. 1. 3. A method of treating psychosis, characterized in that patients are given an effective dose of the compound of formula I according to claim 1. 4. Способ получения соединений формулы I по п. 1, отличающийся тем, что соединение формулы II
Nu-(CH2)n-A,
в которой А и n имеют указанные значения и Nu означает нуклеофильную отходящую группу, подвергают взаимодействию с производным 3-азабицикло[3.2.0] гептана формулы III
Figure 00000008

где R1 означает нафтильную или фенантрильную группу, которые могут быть моно- или дизамещены атомом галоида,
и полученное таким образом соединение в случае необходимости переводят в соль с помощью физиологически приемлемой кислоты.
4. The method of producing compounds of formula I according to claim 1, characterized in that the compound of formula II
Nu- (CH 2 ) n -A,
in which A and n have the indicated meanings and Nu means a nucleophilic leaving group, is reacted with a 3-azabicyclo [3.2.0] heptane derivative of formula III
Figure 00000008

where R 1 means naphthyl or phenanthryl group, which can be mono - or disubstituted by a halogen atom,
and the compound thus obtained is salified, if necessary, with a physiologically acceptable acid.
RU97103533/04A 1994-08-04 1995-07-22 N-substituted 3-azabicyclo (3 RU2160254C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4427647A DE4427647A1 (en) 1994-08-04 1994-08-04 N-substituted azabicycloheptane derivatives, their preparation and use
DEP4427647.8 1994-08-04

Publications (2)

Publication Number Publication Date
RU97103533A true RU97103533A (en) 1999-06-10
RU2160254C2 RU2160254C2 (en) 2000-12-10

Family

ID=6524943

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97103533/04A RU2160254C2 (en) 1994-08-04 1995-07-22 N-substituted 3-azabicyclo (3

Country Status (29)

Country Link
US (1) US5753690A (en)
EP (1) EP0775113B1 (en)
JP (1) JPH10503504A (en)
KR (1) KR970704685A (en)
CN (1) CN1064959C (en)
AT (1) ATE200482T1 (en)
AU (1) AU699021B2 (en)
BG (1) BG63632B1 (en)
CA (1) CA2196700A1 (en)
CZ (1) CZ289080B6 (en)
DE (2) DE4427647A1 (en)
DK (1) DK0775113T3 (en)
ES (1) ES2156212T3 (en)
FI (1) FI970449A (en)
GR (1) GR3035744T3 (en)
HR (1) HRP950437B1 (en)
HU (1) HUT77768A (en)
IL (1) IL114719A (en)
MX (1) MX9700854A (en)
NO (1) NO307376B1 (en)
NZ (1) NZ290429A (en)
PL (1) PL182810B1 (en)
PT (1) PT775113E (en)
RU (1) RU2160254C2 (en)
SI (1) SI9520086B (en)
TW (1) TW378203B (en)
UA (1) UA44736C2 (en)
WO (1) WO1996004245A1 (en)
ZA (1) ZA956476B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836406A1 (en) 1998-08-12 2000-02-17 Basf Ag New S,S-dioxobenzisothiazolinyl-substituted 3-azabicyclo (3.2.0) heptane derivatives, useful e.g. as neuroleptics, antidepressants, hypnotics and sedatives
US6458821B1 (en) 1998-08-12 2002-10-01 Abbott Laboratories N-substituted azabicycloheptane derivatives, production and use thereof
DE19836404A1 (en) * 1998-08-12 2000-02-17 Basf Ag New benzimidazolonyl-substituted 3-azabicyclo (3.2.0) heptane derivatives, useful e.g. as neuroleptics, antidepressants, hypnotics and sedatives
DE19854147A1 (en) * 1998-11-24 2000-05-25 Basf Ag Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative
EP1812389B1 (en) * 2004-10-14 2011-08-17 Abbott GmbH & Co. KG Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
WO2006096757A2 (en) * 2005-03-07 2006-09-14 The University Of North Carolina At Chapel Hill Inhibitors of reca activities for control of antibiotic-resistant bacterial pathogens
FR2953514B1 (en) * 2009-12-09 2011-12-23 Servier Lab NOVEL AZABICYCLO [3.2.0] HEPT-3-YL DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CN112010859B (en) * 2019-05-30 2022-07-19 中国科学院上海药物研究所 Fused ring compound, preparation method and application thereof
CN118356426A (en) * 2023-01-18 2024-07-19 苏州旺山旺水生物医药股份有限公司 Pharmaceutical composition containing fused ring compound and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219973A1 (en) * 1992-06-19 1993-12-23 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use
DE4243287A1 (en) * 1992-06-19 1993-12-23 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use
GB9321481D0 (en) * 1993-10-18 1993-12-08 Alcan Int Ltd Tin oxide
DE4341402A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use

Similar Documents

Publication Publication Date Title
PT85583B (en) ALKYL-4-AMINO-3-KINOLINOMETHANES AND 1- (4-ARYLALHYLAMINO-3-KINOLYLL) -ALCANONES AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RU97103533A (en) DERIVATIVES OF N-SUBSTITUTED AZABICYCLOPTANE AS A NEUROLEPTIC MEANS
KR970704685A (en) N-Substituted Azabicycloheptane Derivatives Useful as Neuroleptics < RTI ID = 0.0 >
DK163055C (en) METHOD OF ANALOGY FOR THE PREPARATION OF 2-DIPROPYLAMINO- (5 OR 7) -FORMYLAMINO-6-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHAL AND PHARMACOLOGICAL ACCEPTABLE ACID ADDITION SALTS.
EA199900156A1 (en) NEW ERYTHROMYCIN DERIVATIVES, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS MEDICAL DOCUMENTS
RU99120682A (en) DERIVATIVES 7- [3- [4- (6-FLUOROZEN [D] ISOXAZOL-3-IL) PIPERIDIN-1-IL] PROPOXY] -CHROMEN-4-OH A, METHOD FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION AND GENERICAHIV HEADSHIV CRAPS. PSYCHOSIS, SCHIZOPHRENIA AND ALLERGY
HUT47266A (en) Process for production of benzimidasole-derivatives and medical compositions containing them
YU133183A (en) Process for obtaining new indolizine derivatives
NO169076C (en) ANHYDRIDES OF 1-ETHYL-6-FLUOR-7-CHLORO-4-OXO-1,4-DIHYDRO-QUINOLIN-3-CARBOXYLIC ACID AND ACID ACID
EP0239500A3 (en) 1-styrene-sulfonyl-2-oxo-5-hydroxy-pyrrolidine derivatives, their intermediates, process for their preparation, compositions containing them and their use as medicines
ATE965T1 (en) AMINOPROPANOL DERIVATIVES OF 2-(O-HYDROXYPHENYL)-PYRROLE, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
DE3381885D1 (en) PIPERIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
DK163237C (en) PHENYL PROPANOLD DERIVATIVES AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS AND QUATERNARY AMMONIUM SALTS THEREOF, PROCEDURES FOR PREPARING IT, PHARMACEUTICAL PREPARATION AND PROCEDURE FOR PROCESSING
DE3465737D1 (en) Process for the preparation of 4-quinolinones
ATE1861T1 (en) HEXAHYDRONAPHTHO(1',2':4,5)IMIDAZO(2,1-B)THIAZOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION.
ES536140A0 (en) PROCEDURE FOR THE PREPARATION OF QUINOLINONAS-4
ES429772A2 (en) Procedure for the preparation of bencilamines. (Machine-translation by Google Translate, not legally binding)
MD113C2 (en) Method of obtaining of phenylkylamine or of salts of this compounds